App-Quantinova.ai

CATASTROPHIC ANTI-PHOSPHOLIPID SYNDROME TRIGGERED BY SEPSIS. A PROSPECTIVE CASE STUDY HIGHLIGHTING BIOLOGICAL CONCEPTS AND MANAGEMENT STRATEGIES IN THIS COMPLEX AND LIFE THREATENING DISEASE.

Minh Hua - European Hematology Association (EHA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

CHOICES: A RANDOMIZED PHASE II TRIAL FOR IMATINIB VS HYDROXYCHLOROQUINE PLUS IM FOR PATIENTS WITH CML IN MCYR WITH RESIDUAL DISEASE DETECTABLE BY Q-PCR

Gillian A. Horne - European Hematology Association (EHA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

Hydroxychloroquine

THE AUTOPHAGY INHIBITOR HYDROXYCHLOROQUINE ADDED TO THALIDOMIDE BASED THERAPY FOR MULTIPLE MYELOMA DEEPENS RESPONSE AND PROLONGS REMISSION IN PATIENTS PREVIOUSLY TREATED WITH THALIDOMIDE.

Stephen O'mara - European Hematology Association (EHA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Hydroxychloroquine

ACTIVATION OF AUTOPHAGY IN ENDOTHELIAL CELLS ENHANCES HEMATOPOIETIC STEM CELLS

Xie-Na Cao - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Hydroxychloroquine

IMPACT OF HYDROXYCHLOROQUINE ON WHO BLEEDING SCORES IN CHRONIC ADULT ITP PATIENTS: RESULTS FORM A THREE-ARM RANDOMIZED CONTROLLED TRIAL (RCT)

Ghada E. M. Abdallah - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Hydroxychloroquine

Lost in Translation: New Cardiomyopathy in a 49-Year-Old Spanish-Speaking Man With Systemic Lupus Erythematosus and Lupus Nephritis

Emily Lau - American Heart Association (AHA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Long-term Treatment With Tadalafil and Hydroxychloroquine Combination Protects Aging Obese Mice Against Myocardial Ischemia/Reperfusion Injury via Down-regulating MicroRNA103

Rui Wang - American Heart Association (AHA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Hydroxychloroquine

Targeting autophagy and immunotherapy with hydroxychloroquine and interleukin 2 in patients with metastatic renal cell carcinoma (mRCC): A Cytokine Working Group study.

Leonard Joseph Appleman - American Society of Clinical Oncology (ASCO) Society for Immunotherapy of Cancer (SITC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

Hydroxychloroquine

Treatment With Hydroxychloroquine or Azithromycin for COVID-19

Rosenberg ES - American College of Cardiology (ACC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Cardiac arrest

Hydroxychloroquine

Observational Study of Hydroxychloroquine for COVID-19

Geleris J - American College of Cardiology (ACC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Hydroxychloroquine

Chloroquine, Hydroxychloroquine, and/or Azithromycin for COVID-19

Qaseem A - American College of Cardiology (ACC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Hydroxychloroquine

Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for COVID-19 - Hydroxychloroquine as Postexposure Prophylaxis for COVID-19

Anthony A. Bavry - American College of Cardiology (ACC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Hydroxychloroquine

Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV-2 Virus II - COALITION II

Anthony A. Bavry - American College of Cardiology (ACC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Arrhythmia

Hydroxychloroquine

Hydroxychloroquine, Azithromycin and Mortality in COVID-19: Meta-Analysis

Fiolet T - American College of Cardiology (ACC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Hydroxychloroquine

Dexamethasone in Hospitalized COVID-19 Patients

Rachel Eshima McKay - American College of Cardiology (ACC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Hydroxychloroquine

OLIGOCLONAL LYMPHOCYTOSIS ASSOCIATED WITH ELEVATED IL6 AND IL10 IN A CASE OF SEVERE CUTANEOUS ADVERSE DRUG REACTION

Yogesh Jeelall - Australasian Society of Clinical Immunology and Allergy (ASCIA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

A STING IN THE TALE

Sophie Willcocks - Australasian Society of Clinical Immunology and Allergy (ASCIA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

A MEATY DRESS

Syed B. Ali - Australasian Society of Clinical Immunology and Allergy (ASCIA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Microscopic colitis

Hydroxychloroquine

Hydroxychloroquine Effect on the Immune System, Coagulation and Lipid Profile in Patients with Thrombotic Primary Antiphospholipid Syndrome

S. Saraiva - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Antiphospholipid syndrome

Hydroxychloroquine

Identification of a COVID-19 Subpopulation Responsive to Hydroxychloroquine Using Machine Learning: The IDENTIFY Trial

C. Lam - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Hydroxychloroquine

Filters

1151 Abstracts